International consensus statement on allergy and rhinology: Allergic rhinitis–2023

SK Wise, C Damask, LT Roland, C Ebert… - International forum of …, 2023‏ - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Challenges of sarcoidosis and its management

M Drent, ED Crouser, J Grunewald - New England Journal of …, 2021‏ - Mass Medical Soc
Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of …

Writing Committee, MM Kittleson, FL Ruberg… - Journal of the American …, 2023‏ - jacc.org
The systemic amyloidoses are a broad spectrum of diseases that result from misfolding of
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …

ERS clinical practice guidelines on treatment of sarcoidosis

RP Baughman, D Valeyre, P Korsten… - European …, 2021‏ - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Sarcoidosis: a clinical overview from symptoms to diagnosis

P Sève, Y Pacheco, F Durupt, Y Jamilloux… - Cells, 2021‏ - mdpi.com
Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …

Sarcoidosis: Epidemiology and clinical insights

M Rossides, P Darlington, S Kullberg… - Journal of internal …, 2023‏ - Wiley Online Library
Sarcoidosis is characterized by noncaseating granulomas which form in almost any part of
the body, primarily in the lungs and/or thoracic lymph nodes. Environmental exposures in …

Neurosarcoidosis: pathophysiology, diagnosis, and treatment

MJ Bradshaw, S Pawate, LL Koth, TA Cho… - Neurology …, 2021‏ - AAN Enterprises
Although often regarded as a protean illness with myriad clinical and imaging
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023‏ - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Diagnosis and treatment of pulmonary sarcoidosis: a review

JA Belperio, F Shaikh, FG Abtin, MC Fishbein… - Jama, 2022‏ - jamanetwork.com
Importance Sarcoidosis is an inflammatory granulomatous disease of unknown cause that
affects an estimated 2 to 160 people per 100 000 worldwide and can involve virtually any …

Treatment of sarcoidosis: a multidisciplinary approach

AK Gerke - Frontiers in immunology, 2020‏ - frontiersin.org
Sarcoidosis is a systemic disease of unknown etiology defined by the presence of
noncaseating granulomatous inflammation that can cause organ damage and diminished …